Stock-based Compensation (Tables)
|
9 Months Ended |
Jun. 28, 2025 |
|---|
| Share-Based Payment Arrangement [Abstract] |
|
| Schedule of Stock Option Activity |
The summary of the Company’s stock option activity is as follows: | | | | | | | | | | | | | | | | | | | | | | | | | Number of Options | | Weighted-Average Exercise Price | | Weighted-Average Remaining Contractual Term | | Aggregate Intrinsic Value | | | | | | (In years) | | (In thousands) | | Outstanding at September 28, 2024 | 7,082,389 | | $ | 14.24 | | | 2.8 | | $ | 210 | | | Exercised | (195,479) | | $ | 13.59 | | | | | | | Forfeited / expired | (1,010,510) | | $ | 14.24 | | | | | | | Outstanding at June 28, 2025 | 5,876,400 | | $ | 14.26 | | | 1.7 | | $ | — | |
|
| Schedule of Restricted Stock Unit Activity |
The summary of the Company’s RSU activity is as follows: | | | | | | | | | | | | | | | | | | | Number of Units | | Weighted-Average Grant Date Fair
Value | | Aggregate Intrinsic Value | | | | | | (In thousands) | | Outstanding at September 28, 2024 | 10,763,098 | | $ | 14.79 | | | $ | 130,772 | | | Granted | 7,252,030 | | $ | 12.41 | | | | | Released | (4,603,993) | | $ | 15.17 | | | | | Forfeited | (3,322,526) | | $ | 13.66 | | | | | Outstanding at June 28, 2025 | 10,088,609 | | $ | 13.28 | | | $ | 108,251 | |
|
| Schedule of Performance Stock Units Activity |
The summary of the Company’s PSU activity is as follows: | | | | | | | | | | | | | | | | | | | Number of Units | | Weighted-Average Grant Date Fair
Value | | Aggregate Intrinsic Value | | | | | | (In thousands) | | Outstanding at September 28, 2024 | 684,080 | | $ | 18.37 | | | $ | 8,312 | | | Granted | 339,837 | | $ | 11.53 | | | | | Released | (7,194) | | $ | 17.54 | | | | Performance adjustment | (121,250) | | $ | 21.80 | | | | | Forfeited | (137,914) | | $ | 17.40 | | | | | | | | | | | Outstanding at June 28, 2025 | 757,559 | | $ | 14.93 | | | $ | 8,129 | |
|
| Schedule of Stock-based Compensation Expense |
Total stock-based compensation expense by functional category was as follows: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Nine Months Ended | | June 28,
2025 | | June 29,
2024 | | June 28,
2025 | | June 29,
2024 | | (In thousands) | | | | | | | | | Cost of revenue | $ | 1,633 | | | $ | 655 | | | $ | 4,588 | | | $ | 1,995 | | | Research and development | 7,944 | | | 9,735 | | | 29,816 | | | 29,133 | | | Sales and marketing | 3,568 | | | 4,510 | | | 13,227 | | | 13,297 | | | General and administrative | 7,639 | | | 7,030 | | | 21,733 | | | 20,536 | | | Total stock-based compensation expense | $ | 20,784 | | | $ | 21,930 | | | $ | 69,364 | | | $ | 64,961 | |
|